Unit profile
Research
Reprogramming somatic cells to induced pluripotent stem (iPS) cells and directed differentiation opens up for studies on neural cells from patients. The Falk group is focusing on fundamental questions in early human neurogenesis. We build cellular models of the healthy and diseased human brain using reprogrammed patient cells. We derive patient specific iPS cells that are further differentiated into patient specific neuroepithelial stem (NES) cells or into 3D brain organoids. We use the cellular models to study proliferation, self-renewal, and differentiation potential as well as the maturation and function of derived neurons to uncover disease mechanisms. The Neural Stem Cells lab is also driving translational projects investigating the regenerative potential of iPS cell derived neural cells in preclinical models with the aim to create ATMPs to take iPS derived cell to clinic. We have derived one of few clinical compliant GMP iPS cell lines that we have banked in a master bank.
Collaborations the last five years
Profiles
-
Linda Eliasson
- MultiPark: Multidisciplinary research on neurodegenerative diseases - Member of Strategic Research Area
- Developmental and Regenerative Neurobiology - Scientific coordinator
- Molecular Neurogenetics - Scientific coordinator
- Neural stem cells - Scientific coordinator
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Member of Strategic Research Area
Person
-
Anna Falk
- Neural stem cells - Research team manager, Professor
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy - Member of Strategic Research Area
- LU-ATMP: Lund University Advanced Therapy Medicinal Products - Director
Person
-
-
An optimized protocol for efficient derivation of pancreatic islets from multiple human pluripotent stem cell lines
Wu, S., Chandel, S., Bryzgalova, G., Efstathopoulos, P., Blust, K., Zhao, C., Erbil, E., Falk, A., Hedhammar, M., Berggren, P. O. & Lanner, F., 2026 May, In: Stem Cell Reports. 21, 5, 102892.Research output: Contribution to journal › Article › peer-review
Open Access -
AI-driven Quality Control of cell-based ATMPs: Automated, Accurate, and Affordable
Magnusson, R., Hägg, A., Twohig, D., Savchenko, E., Ghosheh, N., Melguizo-Sanchis, D., Falk, A. & Synnergren, J., 2026, In: Cytotherapy. 28, 7, 102135.Research output: Contribution to journal › Article › peer-review
Open Access -
Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round
Hägg, A., Wood, R., Mochizuki, A. L., Abberton, K., Abranches, E., Alvarez-Palomo, B., Baptista, R., Quintanilha Barbosa, R. A., Barry, J., Carvalho, A. B., Bennaceur Griscelli, A., Campos de Carvalho, A. C., Chaker, D., Chang, H., Choi, H. Y., Codinach, M., Arán Corbella, B., Cowan, S., Dickerson, S. J. & Elwood, N. & 64 others, , 2026, In: Stem Cell Reports. 21, 4, 102857.Research output: Contribution to journal › Article › peer-review
Open Access
-
NeurXium: Uncovering a novel function for NRXN1a using cellular models of early hindbrain neurodevelopment
Falk, A. (PI)
European Commission - Horizon Europe
2026/04/01 → 2028/03/31
Project: Research
-
Early human neurogenesis and the link to neuropsychiatric conditions
Falk, A. (PI)
2026/01/01 → 2030/12/31
Project: Research
-
Developing novel iPSC derived cell therapy targeting pediatric brain cancer
Falk, A. (PI)
2026/01/01 → 2028/12/31
Project: Research
Activities
-
Kloning och stamceller – med Anna Falk
Falk, A. (Interviewee)
2024 Aug 14Activity: Other › Media participation
-
Stamcellsforskaren: ”Man kan bli botad från nånting som förut var obotligt”
Falk, A. (Interviewee)
2024 May 28Activity: Other › Media participation
File -
“Conducting research at universities is becoming more and more like working at a research hotel”
Falk, A. (Interviewee)
2024 May 23Activity: Other › Media participation
File
Prizes and distinction
-
The Swedish Brain Foundation (Hjärnfonden) – postdoctoral fellowship
Twohig, D. P. (Recipient), 2022 Dec 15
Prize: Other distinction